T1	Participants 81 99	patients with AIDS
T2	Participants 226 282	patients with acquired immunodeficiency syndrome (AIDS).
T3	Participants 656 678	153 eyes, 120 patients
T4	Participants 608 628	35 eyes, 30 patients
